Jade Biosciences Inc. (JBIO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Jade Biosciences Inc.

NASDAQ: JBIO · Real-Time Price · USD
8.86
0.53 (6.36%)
At close: Oct 03, 2025, 3:59 PM
8.35
-5.76%
After-hours: Oct 03, 2025, 05:57 PM EDT

Jade Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
231K 258K 282K 302K 109K 81K 53K 25K
Gross Profit
-231K -258K -282K -302K -109K -81K -53K -25K
Operating Income
-53.12M -51.51M -72.74M -88.4M -94.22M -68.05M -43.43M -21.37M
Interest Income
4.12M 3.68M 4.25M 4.93M 6.34M 4.95M 3.51M 1.8M
Pretax Income
-56.89M -49.53M -70.2M -85.19M -87.88M -63.11M -39.92M -19.56M
Net Income
-56.95M -49.59M -70.26M -85.24M -87.94M -63.16M -39.98M -19.56M
Selling & General & Admin
15.37M 15.03M 16.16M 15.52M 18.08M 13.19M 8.68M 4.46M
Research & Development
37.74M 36.44M 56.52M 72.8M 76.03M 54.78M 34.7M 16.88M
Other Expenses
1.64M 1.64M 1.64M 1.64M n/a n/a n/a n/a
Operating Expenses
54.75M 53.11M 74.31M 89.96M 94.11M 67.97M 43.38M 21.34M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
53.12M 51.51M 72.74M 88.4M 94.22M 68.05M 43.43M 21.37M
Income Tax Expense
55K 55K 55K 56K 56K 56K 56K n/a
Shares Outstanding (Basic)
28.43M 828.14K 828.14K 824.67K 821.6K 794.17K 791.29K 789.73K
Shares Outstanding (Diluted)
28.43M 828.14K 828.14K 824.67K 821.6K 794.17K 791.29K 789.73K
EPS (Basic)
-30.42 -59.44 -85.6 -104.84 -109.92 -79.77 -50.57 -24.77
EPS (Diluted)
-30.42 -59.44 -85.6 -104.84 -109.92 -79.77 -50.57 -24.77
EBITDA
-56.03M -48.65M -69.29M -84.25M -87.77M -63.02M -39.87M -19.54M
EBIT
-56.26M -48.91M -69.57M -84.56M -87.88M -63.11M -39.92M -19.56M
Depreciation & Amortization
231K 258K 282K 302K 109K 81K 53K 25K